8-KExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Exhibit Filing (Feb 11, 2008)

Filed February 11, 2008For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

This Form 8-K filing from JPMorgan Chase & Co. (JPM) on February 11, 2008, primarily serves to file several tax opinions from Davis Polk & Wardwell. These opinions relate to various structured financial products, specifically reverse exchangeable notes and return enhanced notes. The notes are linked to underlying assets such as American Depositary Shares of LM Ericsson Telephone Company and GlaxoSmithKline plc, as well as the Dow Jones EURO STOXX 50® Index and the common stock of Target Corporation. For investors, this filing indicates JPM's continued activity in offering complex, derivative-based investment products. The high coupon rates advertised (e.g., 18.85% per annum and 26.00% per annum) highlight the risk-reward profile associated with these instruments, as they are typically designed for sophisticated investors seeking yield enhancement with a significant exposure to underlying asset performance and market volatility. The filing does not contain new financial results or operational updates but rather legal and tax documentation related to these products.

Key Highlights

  • 1JPMorgan Chase & Co. filed a Form 8-K on February 11, 2008.
  • 2The filing incorporates several tax opinions from Davis Polk & Wardwell.
  • 3These opinions pertain to various structured notes offered by JPM.
  • 4Products include Reverse Exchangeable Notes linked to LM Ericsson, GlaxoSmithKline, and Target Corporation.
  • 5A Return Enhanced Note linked to the Dow Jones EURO STOXX 50® Index is also covered.
  • 6Some notes offer notably high annual equivalent interest rates (e.g., up to 26.00%).
  • 7The filing is primarily administrative, providing legal documentation for financial products.

Frequently Asked Questions

The main purpose of this 8-K filing is to provide legal and tax documentation, specifically tax opinions from Davis Polk & Wardwell, for several structured financial products (notes) that JPMorgan Chase & Co. is offering or has offered.

The filing discusses various types of notes, including Reverse Exchangeable Notes and Return Enhanced Notes. These are linked to underlying assets such as American Depositary Shares of specific companies (LM Ericsson, GlaxoSmithKline), the Dow Jones EURO STOXX 50® Index, and the common stock of Target Corporation.

Some of the notes mentioned offer high stated coupon rates (e.g., 18.85% and 26.00% per annum equivalent). However, these high rates are indicative of the associated risks. Reverse Exchangeable Notes, in particular, typically pay a high coupon but expose the investor to the risk of principal loss if the underlying asset's value declines below a certain threshold. Return Enhanced Notes also carry risks tied to index performance.

No, this filing does not contain any new financial results, earnings updates, or significant operational announcements. It is strictly focused on providing legal and tax opinions for specific structured financial products offered by the company.